Alpha 2.0
Login Register
» Articles » PMID: 28377639

NASH: Novel Therapeutic Strategies Targeting ASK1 in NASH

Overview
Journal Nat Rev Gastroenterol Hepatol
Specialty Gastroenterology
Date 2017 Apr 6
PMID 28377639
Citations 19
Authors
Susanne Schuster
Ariel E Feldstein
Affiliations
Soon will be listed here.
Citing Articles

Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9.

Xin X, Chen C, Xu X, Lv S, Sun Q, An Z Redox Biol. 2025; 80:103499.

PMID: 39879738 PMC: 11815699. DOI: 10.1016/j.redox.2025.103499.

Potential therapeutic strategies for MASH: from preclinical to clinical development.

Xie Z, Li Y, Cheng L, Huang Y, Rao W, Shi H Life Metab. 2025; 3(5):loae029.

PMID: 39872142 PMC: 11749562. DOI: 10.1093/lifemeta/loae029.

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors.

Han X, Lan P, Chen Q, Liu H, Chen Z, Wang T J Enzyme Inhib Med Chem. 2024; 39(1):2414382.

PMID: 39431736 PMC: 11494716. DOI: 10.1080/14756366.2024.2414382.

Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.

Mori T, Yoshio S, Kakazu E, Kanto T Gastroenterol Rep (Oxf). 2024; 12:goae089.

PMID: 39411101 PMC: 11479709. DOI: 10.1093/gastro/goae089.

Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency.

Robinson A, Binek A, Ramani K, Sundararaman N, Barbier-Torres L, Murray B iScience. 2023; 26(2):105987.

PMID: 36756374 PMC: 9900401. DOI: 10.1016/j.isci.2023.105987.

References
1.
Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F . Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie. 2006; 88(9):1091-8. DOI: 10.1016/j.biochi.2006.06.003. View
2.
Wree A, Broderick L, Canbay A, Hoffman H, Feldstein A . From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013; 10(11):627-36. DOI: 10.1038/nrgastro.2013.149. View
3.
Xie L, Wang P, Zhang P, Zhang X, Zhao G, Wang A . DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity. J Hepatol. 2016; 65(1):113-124. DOI: 10.1016/j.jhep.2016.03.008. View
4.
Feldstein A, Canbay A, Angulo P, Taniai M, Burgart L, Lindor K . Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003; 125(2):437-43. DOI: 10.1016/s0016-5085(03)00907-7. View
5.
Xiang M, Wang P, Wang A, Zhang X, Zhang Y, Zhang P . Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. J Hepatol. 2016; 64(6):1365-77. DOI: 10.1016/j.jhep.2016.02.002. View